AMERICAN LUNG ASSOCIATION for AMERICAN LUNG ASSOCIATION
What was lobbied
10 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues relating to the Presidents FY24 budget; Issues relating to FY24 appropriations;
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL G BILLINGS | — |
| RANJANA KODWANI | — |
| ERIKA S SWARD | — |
Clean Air and Water (quality) CAW
Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues relating to the Presidents FY24 budget; Issues relating to FY24 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; HR 277 REINS Act; S 184 REINS Act; H.R. 165 New Source Review Permitting Improvement Act; S. 67 Fair and Transparent Gas Prices Act; S. 240 Gas Stove Protection and Freedom Act; HR 1615 Gas Stove Protection and Freedom Act; HR 1 Lower Energy Costs Act; HR 1435 to prevent the elimination of the sale of combustion vehicles; S 615 Cabin Air Safety Act; HR 1293 Cabin Air Safety Act; S.J. Res. 11 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Control of Air Pollution From New Motor Vehicles; HR 1705 A. Donald McEachin Environmental Justice for All Act; S 919 A. Donald McEachin Environmental Justice for All Act; HR 1023 To repeal section 134 of the Clean Air Act, relating to the greenhouse gas reduction fund; HR 1131 To require the Administrator of the EPA to authorize the use of flexible air permitting with respect to certain critical energy resource facilities, and for other purposes; HR 1140 To authorize the Administrator of the EPA to waive application of certain requirements with respect to processing and refining a critical energy resource at a critical energy resource facility, and for other purposes; HR 1141 Natural Gas Tax Repeal Act;
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL G BILLINGS | — |
Health Issues HCR
Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to the Childrens Health Insurance Program; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to Implementation of ACA; Issues related to Short-Term Limited Duration Plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to the Presidents FY24 budget; Issues relating to FY24 appropriations; HR 277 REINS Act; S 184 REINS Act; HR 1075 Medicaid Work Requirements Act; S. 1063 A bill to amend title XIX of the Social Security Act to implement a minimum work requirement for able-bodied adults enrolled in State Medicaid programs; HR 1551 Jobs and Opportunities for Medicaid Act; H.R. 2583 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2023; H.R. 1114 Long COVID RECOVERY NOW Act; H.R. 1692 Health Care Affordability Act of 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL G BILLINGS | — |
| RANJANA KODWANI | — |
| ERIKA S SWARD | — |
Medical/Disease Research/Clinical Labs MED
Issues relating to the Presidents FY24 budget; Issues relating to FY24 appropriations; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19 Response; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; H.R. 833 Stop the Wait Act;
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL G BILLINGS | — |
| RANJANA KODWANI | — |
| ERIKA S SWARD | — |
Medicare/Medicaid MMM
Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid coverage for immigrants; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues relating to the Presidents FY24 budget; Issues related to regulatory reform; Issues relating to FY24 appropriations; HR 1075 Medicaid Work Requirements Act; S. 1063 A bill to amend title XIX of the Social Security Act to implement a minimum work requirement for able-bodied adults enrolled in State Medicaid programs; HR 1551 Jobs and Opportunities for Medicaid Act; H.R. 2583 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2023; H.R. 1114 Long COVID RECOVERY NOW Act; H.R. 833 Stop the Wait Act;
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL G BILLINGS | — |
| RANJANA KODWANI | — |
| ERIKA S SWARD | — |
Postal POS
Issues related to nonprofit postal rates; Issues related to the Preventing Online Sales of E-cigarettes; Issues relating to the Presidents FY24 budget; Issues relating to FY24 appropriations;
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL G BILLINGS | — |
| ERIKA S SWARD | — |
Defense DEF
Issues related to lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY24 budget; Issues relating to FY24 appropriations;
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL G BILLINGS | — |
| ERIKA S SWARD | — |
Tobacco TOB
Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to the Presidents FY24 budget; Issues relating to FY24 appropriations; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL G BILLINGS | — |
| RANJANA KODWANI | — |
| ERIKA S SWARD | — |
Taxation/Internal Revenue Code TAX
Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues relating to the Presidents FY24 budget; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL G BILLINGS | — |
| RANJANA KODWANI | — |
| ERIKA S SWARD | — |
Veterans VET
Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to the Presidents FY24 budget; Issues relating to FY24 appropriations;
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL G BILLINGS | — |
| RANJANA KODWANI | — |
| ERIKA S SWARD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.